Caitlin John, LLC Fulgent Genetics, Inc. Transaction History
Caitlin John, LLC
- $151 Billion
- Q4 2024
A detailed history of Caitlin John, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Caitlin John, LLC holds 16 shares of FLGT stock, worth $266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$266
Previous $295,000
0.34%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FLGT
# of Institutions
207Shares Held
17.1MCall Options Held
2.36MPut Options Held
47.9K-
Black Rock Inc. New York, NY3.92MShares$65.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$25.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$23.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.05MShares$17.4 Million0.0% of portfolio
-
State Street Corp Boston, MA819KShares$13.6 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $503M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...